Eye Infections: Clinical Trials

337 trials for Eye Infections, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

225 completed, 41 unknown, 22 withdrawn, 19 recruiting. 79 Not applicable, 65 Phase 3, 57 Phase 2, 51 Phase 4, 34 Phase 1.

By phase and status

PhaseTrialsStatus
Not applicable79Completed 50, Unknown 11, Recruiting 6, Terminated 5, Withdrawn 4, Not yet recruiting 2, Active not recruiting 1
Phase 365Completed 46, Unknown 8, Terminated 4, Recruiting 3, Withdrawn 2, Not yet recruiting 1, Suspended 1
Phase 257Completed 36, Withdrawn 6, Unknown 5, Terminated 4, Recruiting 3, Not yet recruiting 2, Active not recruiting 1
Phase 451Completed 38, Withdrawn 5, Unknown 3, Terminated 2, Active not recruiting 1, Not yet recruiting 1, Suspended 1
Phase 134Completed 24, Unknown 3, Withdrawn 3, Recruiting 2, Active not recruiting 1, Terminated 1
Early Phase 13Completed 1, Recruiting 1, Unknown 1

Follow Eye Infections: new trials by email Literature Review of Eye Infections trials Research Report on Eye Infections

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Safety and Efficacy of Intracameral Zimoxin for Prevention of Endophthalmitis After Cataract Surgery
Moxifloxacin, Placebo - Endophthalmitis
Phase 2 / Phase 3Not yet recruitingJason Ahee, M.D.600002027-06-012026-09-15
Fluorometholone Study
Adjunctive Topical Fluorometholone (FML) 0.1%, Standard Topical Antibiotic Therapy - Keratitis Bacterial, Corneal Ulcer (Diagnosis)
Phase 2Not yet recruitingVishal Jhanji1742026-10-312026-06-10
Vitrectomy Combined With Povidone-Iodine Vitreous Irrigation for Infectious Endophthalmitis
Povidone-iodine intravitreal irrigation with povidone-iodine containing 0.0025% available iodine, BSS intravitreal irrigation solution - Endophthalmitis, Infectious Endophthalmitis
Not applicableNot yet recruitingBeijing Tongren Hospital382026-10-302026-10-22
Evaluation of the Impact of Oral Ivermectin on Musca Sorbens Flies, Putative Vector of Trachoma
Ivermectin - Survival of Flies Developing in Faecal Samples
Phase 4Not yet recruitingLondon School of Hygiene and Tropical Medicine122026-07-012026-06-18
Expanding Access to Preventive Chemotherapy Among Mobile and Migrant Populations
Modified Mass Administration of Medicines Strategy, Albendazole 400 mg, Praziquantel 40 mg/kg - Onchocerciasis (River Blindness), Schistosomiasis
Not applicableRecruitingUwemedimo Friday Ekpo57602026-07-012026-07-16
Safety and Efficacy of SUM-191 for Patients With Bacterial Conjunctivitis
SUM-191, Placebo - Bacterial Conjunctivitis
Phase 1 / Phase 2RecruitingSenju USA, Inc.4262026-06-252026-06-30
Evaluation of Safety and Efficacy of Autologous LB-DTK-CMV in Patients With Antiviral-Resistant and Refractory Cytomegalovirus Retinitis.
LB-DTK-CMV - CMV Retinitis
Not applicableRecruitingLucasBio52026-04-272026-07-01
Efficacy of EPD-09-25 for Eyelid Hygiene Before and After Eye Surgery.
EPD Eyelid wipes - Cataract Surgery, Ocular Infections
Not applicableNot yet recruitingVISUfarma SpA1002026-04-012026-02-20
Follow-up Compliance for Corneal Ulcer Patients With SMS Reminder
SMS reminder - Corneal Ulcer
Not applicableRecruitingSeva Canada Society3102026-02-232026-05-12
RESTORE: Comparing Two Approaches to Repeat TT Surgery Performed by Integrated Eye Care Workers (IECWs)
B-RAP, BLTR - Trachoma, Eye Diseases
Not applicableRecruitingUniversity of North Carolina, Chapel Hill10002026-01-132026-04-13
Targeting Immunosuppressive Treatment for Non-infectious Uveitis Using Aqueous Humor Cytokine Profiles
to improve clinical practice in treatment of non-infective uveitis - Uveitis Posterior Non-Infectious, Inflammation Eye
Not applicableActive not recruitingUniversity of Milan2202025-11-152025-12-03
Retrospective Chart Review of Patients With Acanthamoeba Keratitis Who Have Received 0.8 mg/mL Polihexanide as Part of the "Medicines in Special Situations" (Medicamentos en Situaciones Especiales) Program in Spain.
PHMB 0.08% - Acanthamoeba Keratitis
CompletedSIFI SpA232025-10-302026-06-22
Clinical Study of Intrastromal Anti-VEGF Injection for Corneal Neovascularization.
Intrastromal anti-VEGF injection and topical antiviral eye drops, Conventional antiviral topical ocular drops. - Herpes Simplex Keratitis, Corneal Neovascularization
Phase 1 / Phase 2RecruitingSecond Affiliated Hospital, Zhejiang University, School of Medicine1002025-10-012026-01-09
Intrastromal Moxifloxacin as an Adjunctive Therapy in Recalcitrant Bacterial Keratitis
Intrastromal moxifloxacin injection plus standard topical moxifloxacin therapy, Standard topical moxifloxacin therapy alone - Bacterial Keratitis, Recalcitrant Infectious Keratitis
Not applicableRecruitingMinia University602025-10-012026-09-10
Fungal Ulcer Treatment Augmented With Natamycin and Cyclosporine A
Cyclosporine A, Placebo Comparator: Placebo - Fungal Keratitis, Corneal Ulcer
Phase 3RecruitingUniversity of California, San Francisco1502025-09-012026-06-05
Demographics and Clinical Characteristics of Ocular Inflammatory Diseases in Singapore
No Intervention: Observational Cohort - Uveitis, Scleritis and Episcleritis
Active not recruitingSingapore National Eye Centre2002025-08-192025-09-16
Effects of Two Different Eye Care Practices on Eye Complications in Mechanically Ventilated Intensive Care Patients
Control Group: Standard Eye Care Group, Intervention Group 1: Eye Care Using an Eye Care Kit, Intervention Group 2: Eye Care According to an Eye Care Protocol - Eye Care, Nursing Care
Not applicableRecruitingIstanbul Saglik Bilimleri University1562025-07-012026-01-29
Trachoma Elimination Study by Focused Antibiotic (TESFA)
Azithromycin mass treatment, Azithromycin targeted treatment - Trachoma
Phase 4WithdrawnEmory University2025-06-012025-07-16
Efficacy of Fusidic Acid 1% in the Treatment of Bacterial Conjunctivitis
Fusidic Acid 1%, Placebo - Bacterial Conjunctivitis
Phase 3RecruitingBaxis Pharmaceuticals, Inc.4002025-03-212026-03-17
Diagnosing Corneal Infection
Corneal impression membrane (Millicell Cell Culture Insert, 12mm, hydrophilic PTFE 0.4µm (PICM01250)) - Corneal Ulcer (Diagnosis)
WithdrawnUniversity of Edinburgh2025-02-012026-02-27

Showing 20 of 337. Sign in to see all of them.

Narrower conditions

Cytomegalovirus Retinitis (64)  ·  Endophthalmitis (58)  ·  HIV Infections (57)  ·  Corneal Ulcer (55)  ·  Acquired Immunodeficiency Syndrome (46)  ·  Trachoma (38)  ·  Retinitis (37)  ·  Conjunctivitis, Bacterial (35)  ·  Cytomegalovirus Infections (32)  ·  Multiple Acyl Coenzyme A Dehydrogenase Deficiency (32)  ·  AIDS-Related Opportunistic Infections (25)  ·  Keratitis (19)  ·  Conjunctivitis (17)  ·  Conjunctivitis, Viral (14)

Broader conditions

Infections (331)  ·  Eye Diseases (329)  ·  Corneal Diseases (116)  ·  Conjunctival Diseases (101)  ·  Bacterial Infections and Mycoses (100)  ·  Virus Diseases (97)  ·  Eye Infections, Viral (92)  ·  Bacterial Infections (83)  ·  DNA Virus Infections (82)  ·  Conjunctivitis (81)  ·  Herpesviridae Infections (80)  ·  Eye Infections, Bacterial (79)  ·  Retinal Diseases (71)  ·  Urogenital Diseases (70)

Interventions

Azithromycin (32)  ·  Ganciclovir (30)  ·  Moxifloxacin (19)  ·  Foscarnet (13)  ·  Cidofovir (10)  ·  Ivermectin (10)  ·  Ophthalmic Solutions (10)  ·  Gatifloxacin (9)  ·  Lubricant Eye Drops (7)  ·  besifloxacin (7)  ·  Albendazole (6)  ·  Acyclovir (5)  ·  Povidone-Iodine (5)  ·  Probenecid (5)  ·  moxidectin (5)

Sponsors

University of California, San Francisco (24)  ·  National Institute of Allergy and Infectious Diseases (NIAID) (21)  ·  Alcon Research (9)  ·  Hoffmann-La Roche (9)  ·  National Eye Institute (NEI) (9)  ·  Bausch & Lomb Incorporated (8)  ·  Johns Hopkins University (8)  ·  Laboratoires Thea (8)  ·  London School of Hygiene and Tropical Medicine (7)  ·  Federal University of São Paulo (6)  ·  Johns Hopkins Bloomberg School of Public Health (6)  ·  Laboratorios Sophia S.A de C.V. (5)  ·  Merck Sharp & Dohme LLC (5)  ·  NicOx (5)  ·  University of Campinas, Brazil (5)

Countries

United States (131)  ·  Brazil (21)  ·  China (16)  ·  France (16)  ·  United Kingdom (15)  ·  Canada (14)  ·  Egypt (14)  ·  India (14)  ·  Ethiopia (11)  ·  Italy (11)  ·  Germany (10)  ·  Mexico (6)  ·  Poland (6)  ·  Spain (6)  ·  Taiwan (6)

Top investigators

Tom Lietman, MD (6)  ·  Thomas M Lietman, MD (3)  ·  Bala Ambati (2)  ·  Catherine Oldenburg, ScD, MPH (2)  ·  Douglas Jabs, MD (2)  ·  Elodie Lebas, RN (2)  ·  Emily Gower, PhD (2)  ·  Emma Harding-Esch (2)  ·  Fung-Rong Hu, MD (2)  ·  Gerami D Seitzman, MD (2)  ·  Hardy WD (2)  ·  Jennifer Rose-Nussbaumer, MD (2)

Results publications

PMID 31042791, PMID 31589610, PMID 32557558, PMID 21681652, PMID 22953007, PMID 34483270, PMID 35024776, PMID 10832689, PMID 11285665, PMID 11345344, PMID 11520759, PMID 11673290, PMID 11919489, PMID 12095806, PMID 12131029, PMID 12232843, PMID 12386069, PMID 12515932, PMID 12559647, PMID 14765348, PMID 15355406, PMID 15498605, PMID 15642810, PMID 15829742, PMID 16192248, PMID 16257309, PMID 16575115, PMID 16631047, PMID 16905024, PMID 16926355, PMID 17258535, PMID 17420365, PMID 17531690, PMID 17583820, PMID 17652708, PMID 17657018, PMID 17760640, PMID 17996212, PMID 18204773, PMID 18245962, PMID 18374301, PMID 18608899, PMID 18677274, PMID 18829631, PMID 19097643, PMID 19107048, PMID 19107050, PMID 19108788, PMID 19234342, PMID 19329003

NIH funding

U10EY008057 (3), 5UG1EY030833 (2), R01AI048789 (2), U10EY018573 (2), 1UG1EY028088 (1), 1UG1EY036891 (1), 2016 (1), 2019 (1), 2023 (1), K23EY019881 (1), R01EY031033 (1), U01AI027668 (1), U10EY015114 (1), U10EY022584 (1), U10EY022880 (1)